Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9236759 | Clinical Immunology | 2005 | 10 Pages |
Abstract
Currently, the relevance of these innate-like B cells to the pathogenesis of autoimmune disease is the focus of investigation. In experimental models of autoimmunity, the sequestration of autoreactive B cells in the MZ has been proposed to be essential for the maintenance of self-tolerance. The low activation threshold of MZ B cells makes them particularly reactive to high loads and/or altered self-Ags, potentially exacerbating autoimmune disease. Their expansion in autoimmune models and their association with autoantibody secretion indicate that they may participate in tissue damage. The demonstration that B cell depletion therapies may represent a highly beneficial therapeutic goal in autoimmune disorders suggests that specific elimination of B-1 and MZ B cells may represent a more efficient immunointervention strategy in systemic autoimmunity.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Muriel Viau, Moncef Zouali,